Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02362386 · ClinicalTrials.gov registry record
Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System
A clinical trial, sponsored by Cytori Therapeutics.
- Completed
- Registry status
- 17
- Enrollment target
NCT02362386 is a clinical trial that has completed, run by Cytori Therapeutics. The registered enrollment target is 17 participants.
The verdict
NCT02362386 has completed, sponsored by Cytori Therapeutics.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The objective of the study is to assess the logistical and biological feasibility of preparing ADRCs from adipose tissue excised during standard-of-care burn wound excision using the Celution® System for autologous, same-day application to the burn wound.
Interventions
- DEVICE Celution Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02362386
The ClinicalTrials.gov registry entry for NCT02362386 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cytori Therapeutics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Celution Device is the first listed.
NCT02362386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02362386 about?
NCT02362386 is a clinical study titled "Feasibility of Obtaining ADRCs From Discarded Thermal Burn Eschar Tissue Using Investigational Celution® System". The objective of the study is to assess the logistical and biological feasibility of preparing ADRCs from adipose tissue excised during standard-of-care burn wound excision using the Celution® System for autologous, same-day application to the burn wound.
What is the current status of trial NCT02362386?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2015-06. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02362386?
The interventions under investigation include: Celution Device (DEVICE).
Who is sponsoring clinical trial NCT02362386?
This trial is sponsored by Cytori Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.